Jon Harju - CloudMD Software VP Engineering
| DOCRFDelisted Stock | USD 0.03 0 8.50% |
Insider
Jon Harju is VP Engineering of CloudMD Software Services
| Phone | 888-686-8560 |
| Web | https://investors.cloudmd.ca |
CloudMD Software Management Efficiency
The company has return on total asset (ROA) of (0.0595) % which means that it has lost $0.0595 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8836) %, meaning that it generated substantial loss on money invested by shareholders. CloudMD Software's management efficiency ratios could be used to measure how well CloudMD Software manages its routine affairs as well as how well it operates its assets and liabilities.CloudMD Software Services has accumulated 22.13 M in total debt with debt to equity ratio (D/E) of 0.16, which may suggest the company is not taking enough advantage from borrowing. CloudMD Software Services has a current ratio of 1.64, which is within standard range for the sector. Debt can assist CloudMD Software until it has trouble settling it off, either with new capital or with free cash flow. So, CloudMD Software's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CloudMD Software Services sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CloudMD to invest in growth at high rates of return. When we think about CloudMD Software's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Darren Watson | Cogstate Limited | N/A | |
| Chris Edgar | Cogstate Limited | N/A | |
| Rachel Colite | Cogstate Limited | N/A | |
| Gregory MS | National Research Corp | N/A | |
| Ben Stilwill | Streamline Health Solutions | N/A | |
| Jessica Somers | Evolent Health | N/A | |
| Jona Raasch | National Research Corp | 65 | |
| Connor Yuen | EGF Theramed Health | N/A | |
| M Duffy | Evolent Health | 61 | |
| Jawad Shaikh | Streamline Health Solutions | N/A | |
| Helen Hrdy | National Research Corp | 59 | |
| Tunde Sotunde | Evolent Health | N/A | |
| Jim MD | Privia Health Group | N/A | |
| Jacob Goldberger | Streamline Health Solutions | N/A | |
| Craig Barbarosh | Evolent Health | 52 | |
| MB CCS | Streamline Health Solutions | N/A | |
| BEc BEc | Cogstate Limited | 52 | |
| Jon Boumstein | National Research Corp | N/A | |
| Donald Vick | Streamline Health Solutions | 60 | |
| Usama Chaudhry | EGF Theramed Health | 33 | |
| MAAA FSA | Evolent Health | 51 | |
Management Performance
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 |
CloudMD Software Services Leadership Team
Elected by the shareholders, the CloudMD Software's board of directors comprises two types of representatives: CloudMD Software inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CloudMD. The board's role is to monitor CloudMD Software's management team and ensure that shareholders' interests are well served. CloudMD Software's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CloudMD Software's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amit Mathur, Pres Operations | ||
| Eric Lalonde, VP Growth | ||
| Bronwyn Ott, VP HR | ||
| Aida Begovic, Ex Solutions | ||
| Lu Barbuto, Ex Solutions | ||
| Jon Harju, VP Engineering | ||
| Melissa Alvares, VP Marketing | ||
| Adam Kelly, Ex Officer | ||
| Karen MD, President, CEO | ||
| Julia Becker, VP Relations | ||
| Angel Paravicini, Sr Success |
CloudMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CloudMD Software a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (1.06) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 45.4 M | |||
| Shares Outstanding | 293.29 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 0.72 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.29 X |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in CloudMD Pink Sheet
If you are still planning to invest in CloudMD Software Services check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CloudMD Software's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |